First Immunotherapy that can cure Cancer Approved by FDA

Immunotherapy has been around for quite some time, but it is only now that the information is becoming mainstream as people become aware and informed. The Food and Drug Administration just recently approved the first-ever immunotherapy treatment for breast cancer and it is truly a groundbreaking changed in the medical community.

Tecentriq and a form of chemotherapy called Abraxane are combined forms of immunotherapy and they were given accelerated approval for triple negative breast cancer cases. Triple negative breast cancer occurs when the cancer is so advanced that removing the breast is no longer an option.

This treatment works so well in patients with breast cancer, and the approval of the FDA is a huge step forward according to Dr. Peter Schmid, from the Queen Mary University of London while being interviewed by the CNN. The accelerated approval of the FDA is a good sign for a lot of clinics who are currently supporting the use of Immunotherapy. In a study released by the New England Journal of Medicine, they found out that after getting the treatment, patients who underwent immunotherapy gained significant progress with their health condition. The combination therapy allowed them to live longer as cancer stops getting worse after they receive treatment.

What is Immunotherapy?

Immunotherapy is a type of treatment that helps boost and protect the immune system of the body. It treats diseases by activating or suppressing the immune system. There are different forms of how immunotherapy is done, and the drugs that are used here are meant to work in a combined manner along with targeted medicine. Immunotherapy is already a legitimate form of therapy and is now endorsed by top clinics like Feeling Good At Any Age The One-Stop Rejuvenation Center in California. One of the best and leading clinics for various treatments including stem cell therapy. Immunotherapy is now being used to cure certain kinds of cancers including lung cancer, carcinomas and now breast cancer.

900 Women were studied for this Immunotherapy treatment by Tecentriq. The ones who were given the drug had two months where there cancer did not get worse. When compared to the ones who underwent chemotherapy these patients had impressive results. While there are side effects like nerve pain and nausea it is still far more promising. There is a promising future for Immunotherapy and it is here to stay. It will be the new standard o care for patients with cancer even for patients who are not eligible to undergo chemotherapy. Immunotherapy is a perfect option for other patients who cannot tolerate the effects of chemotherapy on their body.

think any of us in the field feel and anticipate that platinum chemotherapy plus immunotherapy will be a new standard of care for patients in the first-line setting. However, even for patients who are not eligible for any chemotherapy, immunotherapy will still also have a role because we know that for the majority of patients who can’t tolerate chemotherapy, immunotherapy still remains a viable option.

Consult An Expert:

You may receive immunotherapy in a doctor’s office, clinic, or outpatient unit in a hospital. Outpatient means you do not spend the night in the hospital. Feeling Good At Any Age The One-Stop Rejuvenation Center is one of the best in the field of stem cell therapy and immunotherapy. You may choose to have treatment every day, week, or month depending on the doctor’s findings.

Book an initial evaluation with FGAAA Clinic ( Feeling Good At Any Age- The One Stop Rejuvenation Center)
FGAAA also provides other revolutionary and advanced procedures like stem cell infusion, HGH, HRT as well as Reluma Cosmetics

Sources:

https://www.curetoday.com/articles/past-present-and-future-immunotherapy-is-here-to-stay

https://www.ajc.com/news/national/fda-gives-immunotherapy-drug-tecentriq-approval-treat-breast-cancer/R0xEOItVylNzQxrZeoeqXM/

Leave a Reply

avatar
  Subscribe  
Notify of